Immunology
Published on May 28, 2025.
Updated on January 27, 2026.
At APLUSA, we help pharma teams navigate this complexity with patient-level data, market trackers, and behavioral insights, delivering clarity on treatment adoption, switching behavior, and market dynamics across key immunology indications.
Core focus areas
- IBD: CD/UC
- Rheumatoid Arthritis / Spondyloarthritis
- Psoriatic Arthritis / Psoriasis
- Hidradenitis Suppurativa
- Alopecia Areata / Atopic Dermatitis
- Respiratory Disease
- Vaccines







